China is likely to seek more concessions from drugmakers

04/9/2013 | Bloomberg

The Chinese government is likely to seek pricing concessions from drugmakers on expensive cancer medicines and might resort to compulsory licensing in some cases, former health minister Chen Zhu said. Annual spending on health care in China is expected to reach $1 trillion by 2020, according to a McKinsey & Co. analysis.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL